About KLISBio
KLISBio is a company based in Bresso (Italy) founded in 2013 by Antonio Alessandrino and Gabriele Grecchi.. KLISBio has raised $8.58 million across 8 funding rounds from investors including European Union, ComoNExT and Principia SGR. KLISBio offers products and services including Nerve Repair Implant, Bone Grafting Material, Tendons and Ligaments Repair Product, and Vascular Graft. KLISBio operates in a competitive market with competitors including Checkerspot, Fermbox, Bcomp, Industrial Microbes and FibroHeal, among others.
- Headquarter Bresso, Italy
- Founders Antonio Alessandrino, Gabriele Grecchi
-
Sectors
HealthcareChemicals & Materials Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Klisbio S.R.L.
-
Annual Revenue
-
Net Profit
$-432.15 K (USD)44as on Dec 31, 2023
-
EBITDA
$-432.15 K (USD)44as on Dec 31, 2023
-
Total Equity Funding
$8.58 M (USD)
in 8 rounds
-
Latest Funding Round
$7.94 M (USD), Series A
Apr 21, 2016
-
Investors
European Union
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KLISBio
KLISBio offers a comprehensive portfolio of products and services, including Nerve Repair Implant, Bone Grafting Material, Tendons and Ligaments Repair Product, and Vascular Graft. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implant for repairing nerves using silk fibroin material.
Material for promoting bone regeneration in surgical procedures.
Product for repairing soft tissues like tendons and ligaments.
Graft for vascular applications to support tissue regeneration.
Unlock access to complete
Unlock access to complete
Funding Insights of KLISBio
KLISBio has successfully raised a total of $8.58M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $7.94 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $7.9M
-
First Round
First Round
(01 Dec 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2016 | Amount | Series A - KLISBio | Valuation | Principia SGR |
|
| Jul, 2015 | Amount | Grant - KLISBio | Valuation |
investors |
|
| Jun, 2015 | Amount | Grant - KLISBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KLISBio
KLISBio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, ComoNExT and Principia SGR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in Italian tech and life sciences are targeted.
|
Founded Year | Domain | Location | |
|
Business incubation and acceleration for exponential technologies are provided.
|
Founded Year | Domain | Location | |
|
Startup incubation for SMEs is facilitated by ComoNExT.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KLISBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KLISBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Klisbio Comparisons
Competitors of KLISBio
KLISBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Checkerspot, Fermbox, Bcomp, Industrial Microbes and FibroHeal, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
High-performance materials are developed using synthetic biology for diverse applications.
|
|
| domain | founded_year | HQ Location |
Alternative animal products are developed via microbial precision fermentation.
|
|
| domain | founded_year | HQ Location |
Sustainable biomaterials for lightweighting in automotive and aerospace are provided.
|
|
| domain | founded_year | HQ Location |
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals
|
|
| domain | founded_year | HQ Location |
Developer of silk proteins as biomaterials for wound healing
|
|
| domain | founded_year | HQ Location |
Engineering agri-waste into purpose
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about KLISBio
When was KLISBio founded?
KLISBio was founded in 2013.
Where is KLISBio located?
KLISBio is headquartered in Bresso, Italy. It is registered at Bresso, Lombardy, Italy.
Who is the current CEO of KLISBio?
Gabriele Grecchi is the current CEO of KLISBio. They have also founded this company.
Is KLISBio a funded company?
KLISBio is a funded company, having raised a total of $8.58M across 8 funding rounds to date. The company's 1st funding round was a Grant of $55K, raised on Dec 01, 2013.
What does KLISBio do?
KLISBio was founded in 2013 in Bresso, Italy, within the biotechnology sector focused on regenerative medicine. A silk-based technology platform is employed to create scaffold materials addressing peripheral nerve injuries, vascular diseases, bone defects, tendon tears, and needs for sustained drug release. Operations center on developing implantable products for these indications, with research and development conducted from the companys Italian base.
Who are the top competitors of KLISBio?
KLISBio's top competitors include Checkerspot, FibroHeal and Bloom Biorenewables.
What products or services does KLISBio offer?
KLISBio offers Nerve Repair Implant, Bone Grafting Material, Tendons and Ligaments Repair Product, and Vascular Graft.
Who are KLISBio's investors?
KLISBio has 6 investors. Key investors include European Union, ComoNExT, Principia SGR, Singularity, and PNICube.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.